MDC Berlin

Colon cancer stem cells have one weak spot: the enzyme Mll1. An MDC team led by Walter Birchmeier has now shown in Nature Communications that blocking this protein prevents the development of new tumors in the body.

In order for the human immune system to effectively fight off pathogens, B cells need to smash up and reassemble their own DNA. Michela Di Virgilio searches for factors controlling this important process, which also have crucial implications for our predisposition to cancer.

A muscle fiber consists of just one cell, but many nuclei. A team at the MDC led by Professor Carmen Birchmeier has now shown just how varied these nuclei are. The study, which has been published in Nature Communications, can help us better understand muscle diseases such as Duchenne muscular dystrophy.

The European Research Council (ERC) awarded Dr. Mina Gouti a €2.8 million Consolidator Grant to further develop miniature neuromuscular organoids for studying neuromuscular development and diseases. It was the second honor in as many weeks; she was also named an EMBO Young Investigator for her work.

We have known about a skin touch sensor for more than 160 years. MDC scientists now publish in Nature Neuroscience some of the first proof of its involvement in detecting tiny vibrations that help us to distinguish between a rough or a smooth surface.

At MDC, we do research to promote human health and well-being. In our labs we employ cell cultures, organoids and computer models. We seek and develop alternatives to animal experiments. It remains a fact that, biomedical research is not possible without animal experiments. Our researchers tell us why.

PhD candidates now have the opportunity to apply for two new training programs. The EU is supporting the program for talented early-stage researchers at the MDC and other European research institutions to the tune of €4 million per network.

The process of cells multiplying is one of the most well-understood processes in life. When MDC biologists joined forces with a physicist and mathematician, they gained new and unexpected insights about the cell cycle, now published in “Molecular Systems Biology”.

Highly sensitive ultrasound devices, state-of the-art MRI scanners, germ-free climatic chambers: The MDC’s Preclinical Research Center creates the best conditions for necessary animal testing in medical research, making sure animals suffer as little as possible and reducing the number of animals used to a minimum.

A team led by Oliver Daumke at the MDC has determined the three-dimensional structure of the NatC acetyltransferase in an article published in Nature Communications. This enzyme modifies cell proteins to enable them to perform their functions correctly. In cancer cells, however, NatC is often overactive.

Female moles not only have ovarian, but also testicular tissue that produces male sex hormones – which lets them diverge from the categorization into two sexes. A team led by Berlin researchers Stefan Mundlos and Darío Lupiáñez describes in Science which genetic modifications contribute to this singular development.

Researchers from three continents have produced a first extensive draft of a cell atlas of the human heart to understand how this vital organ functions and to shed light on what goes wrong in cardiovascular disease. As the team reports in Nature, it reveals a huge cellular and molecular diversity.

Berlin has a long tradition as a medical metropolis and also the potential to become an international hub for the life sciences, comparable to Boston. On September 28, researchers from both cities will discuss this issue with the Governing Mayor of Berlin, Michael Müller.

Berlin will become one of four new National Center for Tumor Diseases (NCT) locations in addition to Heidelberg and Dresden. This was announced today by the Federal Ministry of Education and Research, recognizing the outstanding achievements of Charité, the BIH and the MDC in advancing cancer treatment and research.

Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime Strategic Research Agenda they now present a roadmap of how to leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.